| 06-03-2008 01:38 PM CET - Science & Education |
|
Trevigen announces the release of Four New Assay Kits for 3-D Cell Proliferation
Press release from: Trevigen, Inc.
(openPR) - Many scientists are converting from growing cells in a traditional 2-D Monolayer on plastic surfaces with tissue culture medium to ā3-Dā Culture. In 3-D Culture, cells are grown in a microenvironment of specialized proteins which mimics in vivo conditions and allows the cells to organize into complex structures rather than uniform monolayers. Various types of cells require different specialized proteins for optimal growth conditions and these extracellular matrices can play an important role in modulating cellular response to pharmacological compounds. For these reasons, conversion to 3-D culture with different matrices is highly desirable, but until now there has not been a practical way to evaluate cell proliferation from 3-D cultures.
Trevigen has an innovative solution with the introduction of four new 3-D cell proliferation kits including a core kit and three different kits containing basement membrane extract, laminin I, and collagen I. These are the first standardized kits engineered for assessing the effects of compounds or genetic alteration on cell proliferation in 3-D culture. The high throughput 96 stripwell formats allow one step quantitative analysis and colorimetric detection. Protocols are provided for tumorgenicity and cytotoxicity.
Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of products and technology for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior. Trevigen has been a long-standing provider of quality reagents and kits for researchers investigating programmed cell death and DNA damage and repair. A logical extension of the focus on cancer research has been the recent development of assays for cancer cell function and behavior including angiogenesis, cell invasion and tumor formation. Currently, the product portfolio contains over 500 products categorized into four processes ā Apoptosis, DNA Damage and Repair, Angiogenesis, and
Oxidative Stress. 3-D qualified BME, Laminin I and Collagen I are also available separately from Trevigen. Visit www.trevigen.com or contact us at 1800-873-8443 or info@trevigen.com for more information.
Trevigen, Inc.
8405 HELGERMAN CT.
GAITHERSBURG, MD 20877
Phone: 1.800. TREVIGEN
Fax: 1.301.560.4973
Email: INFO@TREVIGEN.COM
Web: www.trevigen.com
Trevigen has been a long standing provider of quality kits and reagents for researchers investigating programmed cell death, DNA damage and repair, cell differentiation and angiogenesis.
Trevigen has an innovative solution with the introduction of four new 3-D cell proliferation kits including a core kit and three different kits containing basement membrane extract, laminin I, and collagen I. These are the first standardized kits engineered for assessing the effects of compounds or genetic alteration on cell proliferation in 3-D culture. The high throughput 96 stripwell formats allow one step quantitative analysis and colorimetric detection. Protocols are provided for tumorgenicity and cytotoxicity.
Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of products and technology for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior. Trevigen has been a long-standing provider of quality reagents and kits for researchers investigating programmed cell death and DNA damage and repair. A logical extension of the focus on cancer research has been the recent development of assays for cancer cell function and behavior including angiogenesis, cell invasion and tumor formation. Currently, the product portfolio contains over 500 products categorized into four processes ā Apoptosis, DNA Damage and Repair, Angiogenesis, and
Oxidative Stress. 3-D qualified BME, Laminin I and Collagen I are also available separately from Trevigen. Visit www.trevigen.com or contact us at 1800-873-8443 or info@trevigen.com for more information.
Trevigen, Inc.
8405 HELGERMAN CT.
GAITHERSBURG, MD 20877
Phone: 1.800. TREVIGEN
Fax: 1.301.560.4973
Email: INFO@TREVIGEN.COM
Web: www.trevigen.com
Trevigen has been a long standing provider of quality kits and reagents for researchers investigating programmed cell death, DNA damage and repair, cell differentiation and angiogenesis.
News-ID: 46065
More releases
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Ā© openPR 2012 | Imprint
More Releases from
Trevigen, Inc.
Comments about openPR
Your portal is fast, simple, and easy to use. Others may have more functions but they also demand more editing time, you have to preformat the text in order to achieve a good result etc.
I think openPR is really fantastic!
Andreas Knepper, wallmedien AG
I think openPR is really fantastic!
Andreas Knepper, wallmedien AG


